IL33 and breast cancer: In subsequent studies, Gao et al. [77] showed that over-expression of IL-33 in B16 melanoma and 4T1 breast cancer cells inhibited tumor growth and metastasis by increasing the numbers and IFN-γ production of CD8+ T and NK cells in tumor tissues, creating a TME that favored the eradication of tumors [77].